GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (FRA:3JR) » Definitions » 3-Year ROIIC %

Sopharma AD-Sofia (FRA:3JR) 3-Year ROIIC % : 147.28% (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Sopharma AD-Sofia 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Sopharma AD-Sofia's 3-Year ROIIC % for the quarter that ended in Dec. 2023 was 147.28%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Sopharma AD-Sofia's 3-Year ROIIC % or its related term are showing as below:

FRA:3JR's 3-Year ROIIC % is ranked better than
96.74% of 92 companies
in the Medical Distribution industry
Industry Median: 0.99 vs FRA:3JR: 147.28

Sopharma AD-Sofia 3-Year ROIIC % Historical Data

The historical data trend for Sopharma AD-Sofia's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma AD-Sofia 3-Year ROIIC % Chart

Sopharma AD-Sofia Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.52 -5.38 18.69 38.83 147.28

Sopharma AD-Sofia Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.83 - - - 147.28

Competitive Comparison of Sopharma AD-Sofia's 3-Year ROIIC %

For the Medical Distribution subindustry, Sopharma AD-Sofia's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sopharma AD-Sofia's 3-Year ROIIC % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Sopharma AD-Sofia's 3-Year ROIIC % falls into.



Sopharma AD-Sofia 3-Year ROIIC % Calculation

Sopharma AD-Sofia's 3-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( 43.7746752 (Dec. 2023) - 22.63662 (Dec. 2020) )/( 528.671 (Dec. 2023) - 514.319 (Dec. 2020) )
=21.1380552/14.352
=147.28%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Sopharma AD-Sofia  (FRA:3JR) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Sopharma AD-Sofia 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sopharma AD-Sofia (FRA:3JR) Business Description

Traded in Other Exchanges
Address
5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are organized based on the production of finished products which include Tablet dosage forms, Ampoule dosage forms, Medical products, Other forms, and Other revenue. Geographically company operates in Bulgaria and internationally.

Sopharma AD-Sofia (FRA:3JR) Headlines

No Headlines